Sezary Syndrome Monitoring: Whole Blood Flow Cytometry with Fluorescent Markers
This test helps monitor a rare, aggressive blood cancer called Sezary syndrome by analyzing your blood cells for specific changes associated with the disease.
["It helps track disease progression and response to treatment by detecting abnormal T-cells linked to Sezary syndrome."]
Key facts at a glance
- LOINC
- 101117-0
- Short code
- Sezary syndrome monitoring Bld Doc FC
- Synonyms
- Sezary syndrome monitoring Bld Doc FC
- Category
- chemistry
- Sample
- whole-blood
- Container
- Lavender-top (EDTA)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- flow-cytometry
- Specimen volume
- 3 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h
- Hemolysis max
- 0
- Lipemia max
- 0
- Icterus max
- 0
- TAT
- 4–24 hours
- Order
- routine
What Does This Test Measure?
This test examines your whole blood using flow cytometry—a technique that separates and analyzes individual cells based on their size, shape, and surface markers. Special fluorescent dyes bind to specific proteins on your T-cells, allowing the lab to identify and count abnormal cells linked to Sezary syndrome.
Why Is This Test Important?
Sezary syndrome is characterized by a proliferation of abnormal T-cells in the blood, skin, and lymph nodes. This test helps doctors monitor the number and behavior of these cells to assess disease activity, guide treatment decisions, and evaluate how well your body is responding to therapy.
How Is the Test Performed?
A small blood sample is drawn from a vein, typically in your arm. The sample is then processed in the lab to isolate your blood cells. Fluorescent markers are added to identify and count specific cell types, including those characteristic of Sezary syndrome.
What Are the Clinical Implications?
High levels of abnormal T-cells detected in this test may indicate active Sezary syndrome. Regular monitoring helps doctors adjust treatments, such as chemotherapy, immunotherapy, or targeted therapies, to manage symptoms and slow disease progression.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
This test is critical for diagnosing Sezary syndrome, assessing its severity, and monitoring treatment effectiveness. It provides key data to guide personalized cancer care and long-term management plans.
Short name
Sezary Syndrome Blood Test
Frequently asked questions
How often will I need this test?
What do abnormal results mean?
Can I prepare for this test?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy